Cellter logo — Artificial intelligence powered Big data to speed up the sea...

Cellter

Artificial intelligence powered Big data to speed up the search for life-saving diagnostics, medicines, and therapies

Founded 2016 Chile Chile 3 employees AI, Biotechnology +2

General Information

Company Name Cellter
Founded Year 2016
Location Chile Chile +1
Employees 3
Industries AI, Biotechnology, Health Care +1
Social

Get notified when Cellter moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cellter

Cellter is an AI-powered biotech startup founded in 2016, aiming to revolutionize drug discovery and development. Focused on addressing the increasing rates of Cardiovascular Diseases (CVDs) and Cancer, the company leverages big data and AI to accelerate the search for life-saving diagnostics, medicines, and therapies. With WHO estimates projecting an up to 70% increase in new cases of these diseases in the next 20 years, Cellter recognizes the urgency to expedite the drug development process. Particularly focused on the faster-aging region in the world, Latin America, Cellter acknowledges that only 5% of the populations in this region are studied in drug development processes, highlighting the need for a more inclusive approach. The company aims to bridge the equation between time, costs, risk, and efficiency by creating innovative nano drugs and finding new therapies for unmet medical needs. This strategic approach not only targets high incidence diseases but also aims to deliver life-changing innovations for all. With a strong focus on AI, biotechnology, healthcare, and pharmaceuticals, Cellter presents a promising solution to the pressing challenges in the pharmaceutical industry, positioning itself as a potential investment opportunity for venture capitalists looking to support groundbreaking advancements in healthcare.

Taxonomy: Biotech, AI-powered drug design, Nano drugs, Diagnostics, Therapies, Cardiovascular Health, Cancer Treatment, Immunotherapy, Regenerative Medicine, R&D Economics, Nanopharmaceutics, High-Incidence Diseases

No funding data available for Cellter yet.

Get notified when Cellter raises funding

Cellter Alternatives & Competitors

Cellter vs
Parkinson's UK
Parkinson's UK United Kingdom

We’ll find a cure. Together. Powered by people. Funded by you. Improving life for everyone affected...

661 employees
Cellter vs
Tango Therapeutics
Tango Therapeutics United States

Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medic...

Post Ipo Equity
157 employees
Biotechnology, Health Care
Cellter vs

Global nonprofit that encourages and equips young adults to be ready for real life.

27 employees
Education

FAQ About Cellter

Artificial intelligence powered Big data to speed up the search for life-saving diagnostics, medicines, and therapies
Cellter was founded in 2016.
Cellter is headquartered in Chile.
Cellter operates in the following industries: AI, Biotechnology, Health Care, Pharmaceutical.
Cellter has approximately 3 employees.
Top alternatives and competitors to Cellter include Parkinson's UK, Tango Therapeutics, Growing Leaders, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cellter and Parkinson's UK are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cellter and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy